Amsorb Plus and Drägersorb Free, two new-generation carbon dioxide absorbents that produce a low compound A concentration while providing sufficient CO2 absorption capacity in simulated sevoflurane anesthesia

Journal of Anesthesia

Volumn 18, Issue 4, 2004, Pages 277-281

  Kobayashi, Shunji ^a   Bito, Hiromichi ^b   Morita, Koji ^a   Katoh, Takasumi ^a   Sato, Shigehito ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Bato Clinic   (Japan)

Author keywords

CO2 absorbent; CO2 absorption capacity; Compound A; Low flow anesthesia; Sevoflurane

Indexed keywords

2 FLUOROMETHYL 2 DIFLUORO 1 (TRIFLUOROMETHYL)VINYL ETHER; ABSORBENT; CARBON DIOXIDE; SEVOFLURANE; UNCLASSIFIED DRUG;

ABSORPTION; ANESTHETIC EQUIPMENT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FLOW RATE; GAS FLOW; INHALATION ANESTHESIA; SIMULATION;

ABSORPTION; ANESTHESIA; ANESTHETICS, INHALATION; CALCIUM CHLORIDE; CALCIUM HYDROXIDE; CARBON DIOXIDE; ETHERS; HYDROCARBONS, FLUORINATED; METHYL ETHERS;

EID: 8444243669     PISSN: 09138668     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00540-004-0253-5     Document Type: Article

References (23)

1. Morio M, Fujii K, Satoh N, Imai M, Kawakami U, Mizuno T, Kawai Y, Ogasawara Y, Tamura T, Negishi A, Kumagai Y, Kawai T (1992) Reaction of sevoflurane and its degradation products with soda lime: Toxicity of the byproducts. Anesthesiology 77:1155-1164
2. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, Kerschmann RL (1994) Toxicity of compound A in rats: Effect of a 3-hour administration. Anesthesiology 80:556-565
3. Gonsowski CT, Laster MJ, Eger EI II, Ferrell LD, Kerschmann RL (1994) Toxicity of compound A in rats: Effect of increasing duration of administration. Anesthesiology 80:566-573
4. Kharasch ED, Thorning D, Garton K, Hankins DC, Kilty CG (1997) Role of renal cysteine β-lyase in the mechanism f compound A nephrotoxicity in rats. Anesthesiology 86:160-171
5. Kharasch ED, Hoffman GM, Thorning D, Hankins DC, Kilty CG (1998) Role of the renal cysteine conjugate β-lyase pathway in inhaled compound A nephrotoxicity in rats. Anesthesiology 88:1624-1633
6. Mazze RI, Jamison RL (1997) Low-flow (1 l/min) sevoflurane: Is it safe? Anesthesiology 86:1225-1227
7. Eger EI II, Koblin DD, Bowland T, Ionescu P, Laster MJ, Fang Z, Gong D, Sonner J, Weiskopf RB (1997) Nephrotoxicity of sevoflurane versus desflurane anesthesia in volunteers. Anesth Analg 84:160-168
8. Ebert TJ, Frink EJ, Kharasch ED (1998) Absence of biochemical evidence for renal and hepatic dysfunction after 8 hours of 1.25 minimum alveolar concentration sevoflurane anesthesia in volunteers. Anesthesiology 88:601-610
9. Higuchi H, Sumita S, Wada H, Ura T, Ikemoto T, Nakai T, Kanno M, Satoh T (1998) Effects of sevoflurane and isoflurane on renal function and on possible markers of nephrotoxicity. Anesthesiology 89:307-322
10. Obata R, Bito H, Ohmura M, Moriwaki G, Ikeuchi Y, Katoh T, Sato S (2000) The effects of prolonged low-flow sevoflurane anesthesia on renal and hepatic function. Anesth Analg 91:1262-1268
11. Kharasch ED, Powers KM, Artru AA (2002) Comparison of Amsorb, Sodalime, and Baralyme degradation of volatile anesthetics and formation of carbon monoxide and compound A in swine in vivo. Anesthesiology 96:173-182
12. Murray JM, Renfrew CW, Bedi A, McCrystal CB, Jones DS, Fee JPH (1999) Amsorb: A new carbon dioxide absorbent for use in anesthetic breathing systems. Anesthesiology 91:1342-1348
13. Mchaourab A, Arain SR, Ebert TJ (2001) Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans. Anesthesiology 94:1007-1009
14. Higuchi H, Adachi Y, Arisuma S, Kanno M, Satoh T (2001) The carbon dioxide absorption capacity of Amsorb is half that of soda lime. Anesth Analg 93:221-225
15. Ueyama H, Takashina M, Suzuki T, Sriranganathan V, Mashimo T (2000) Warning: Carbon dioxide absorption capacity of Amsorb was unexpectedly low in low-flow anesthesia. Anesthesiology 93:1560-1561
16. 2 absorbent on compound A production in vitro. Anesthesiology 91: A400
17. Cunningham DD, Huang S, Webster J, Mayoral J, Grabenkort RW (1996) Sevoflurane degradation to compound A in anaesthesia breathing systems. Br J Anaesth 77:537-543
18. 2 absorbent in a standard anesthetic circuit. J Anesth 14:143-146
19. Stabernack CR, Brown R, Laster MJ, Dudziak R, Eger EI II (2000) Absorbents differ enormously in their capacity to produce compound A and carbon monoxide. Anesth Analg 90:1428-1435
20. Higuchi H, Adachi Y, Arimura S, Kanno M, Satoh T (2000) Compound A concentrations during low-flow sevoflurane anesthesia correlate directly with the concentration of monovalent bases in carbon dioxide absorbents. Anesth Analg 91:434-439
21. Mchaourab A, Arain SR, Ebert TJ (2001) Lack of degradation of sevoflurane by a new carbon dioxide absorbent in humans. Anesthesiology 94:1007-1009
22. Bito H, Ikeda K (1995) Effect of total flow on the concentration of degradation products generated by reaction between sevoflurane and soda lime. Br J Anaesth 74:667-669
23. Fang ZX, Eger EI II, Laster MJ, Chortkoff BS, Kandel L, Ionescu P (1995) Carbon monoxide production from degradation of desflurane, enflurane, isoflurane, halothane, and sevoflurane by soda lime and Baralyme. Anesth Analg 80:1187-1193